Anti-hepatoma effect of suicide gene therapy using HSV/TK combined with ganciclovir in hepatoma cells

Yongfang Li,Yingmin Zhang,Na Zhao,Fanxiu Meng,Qi Zhang,Ranpeng Gao,Yuehong Zhang,Baofeng Yu,Rui Guo,Hailong Wang,Jun Xie,Jun Xu

DOI: https://doi.org/10.3877/cma.j.issn.1674-0785.2016.02.017

2016-01-01

Abstract:ObjectiveThe present study was performed to investigate the selective cytotoxicity of pcDNA3.1-pSurvivin-TK suicide gene expression level in HepG2 hepatoma cells driven by the Survivin promoter. And to evaluate the cytotoxicity of pcDNA3.1-pSurvivin-TK suicide gene on hepatoma cells. Thus, it can lay a foundation for the liver cancer gene therapy.MethodsThe plasmid was transfected into the HepG2 hepatoma cells with liposomes, we detected the expression levels of pcDNA3.1-pSurvivin-TK suicide gene in liver cells and hepatoma cells by RT-PCR and Western blot method. In addition, transfecting pcDNA3.1-pSurvivin-TK plasmid vector into HepG2 hepatoma cells with lipoplexes vectors, with increasing of ganciclovir doses we explored the cytotoxicity of pcDNA3.1-pSurvivin-TK plasmid vector on hepatoma cells with CCK-8 reagents and flow cytometry.Results The pcDNA3.1-pSurvivin-TK plasmid vector expression level was higher in hepatoma cells than in the control group without transfecting the plasmid. Additionally, CCK-8 assay indicated, increasing the dose of ganciclovir into the cell with transfected the plasmid vector, the cytotoxicity of pcDNA3.1-pSurvivin-TK suicide gene gradually increased. With flow cytometry, the cytotoxicity of the transfected hepatoma cells with the vector and&nbsp;untransfected cells were (37.37±4.02)% and (1.0±0.62)% separately with the difference being significant among them (P<0.01).Conclusion The result verified the cytotoxicity of pcDNA3.1-pSurvivin-TK suicide gene on HepG2 hepatoma cells with different doses of GCV. What’s more, our experiments laid a foundation for the liver-targeted gene therapy.